EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Exploring the impact of N4-acetylcytidine modification in RNA on non-neoplastic disease: unveiling its role in pathogenesis and therapeutic opportunities

Keyu Wan, Tiantian Nie, Wenhao Ouyang iD, Yunjing Xiong, Jing Bian, Ying Huang, Li Ling, Zhenjun Huang, Xianhua Zhu iD

Briefings in Functional Genomics · 2025

DOI: 10.1093/bfgp/elae020 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Briefings in Functional Genomics, 2025. Verfasst von Keyu Wan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China. Hauptthemen laut MEDLINE: Cytidine, RNA, RNA Processing, Post-Transcriptional. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Science and Technology Project of Shenzhen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA modifications include not only methylation modifications, such as m6A, but also acetylation modifications, which constitute a complex interaction involving “writers,” “readers,” and “erasers” that play crucial roles in growth, genetics, and disease. N4-acetylcytidine (ac4C) is an ancient and highly conserved RNA modification that plays a profound role in the pathogenesis of a wide range of diseases. This review provides insights into the functional impact of ac4C modifications in disease and introduces new perspectives for disease treatment. These studies provide important insights into the biological functions of post-transcriptional RNA modifications and their potential roles in disease mechanisms, offering new perspectives and strategies for disease treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytidineRNARNA Processing, Post-TranscriptionalHumansAnimals

Stichwörter der Autor:innen

N4-acetylcytidine (ac4C)RNA modificationbiological functiondiseasestreatment

Substanzen

CytidineRNAN-acetylcytidine

Autor:innen und Institutionen

  • Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
  • The First Clinical Medical College, Nanchang University, Nanchang 330006, China.
  • Department of Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.
  • The Second Clinical Medical College, Nanchang University, Nanchang 330006, China.
  • Department of Neurology, Shenzhen Hospital, Southern Medical University, Shenzhen 518000, China.

ORCID-Profile: Wenhao Ouyang, Xianhua Zhu

Förderung

  • Science and Technology Project of Shenzhen

Zitieren

APA

Wan, K., Nie, T., Ouyang, W., Xiong, Y., Bian, J., Huang, Y., Ling, L., Huang, Z., & Zhu, X. (2025). Exploring the impact of N4-acetylcytidine modification in RNA on non-neoplastic disease: unveiling its role in pathogenesis and therapeutic opportunities. Briefings in Functional Genomics. https://doi.org/10.1093/bfgp/elae020

Vancouver

Wan K, Nie T, Ouyang W, Xiong Y, Bian J, Huang Y, et al. Exploring the impact of N4-acetylcytidine modification in RNA on non-neoplastic disease: unveiling its role in pathogenesis and therapeutic opportunities. Briefings in Functional Genomics. 2025. doi:10.1093/bfgp/elae020

BibTeX
@article{Wan2025,
  author = {Wan, Keyu and Nie, Tiantian and Ouyang, Wenhao and Xiong, Yunjing and Bian, Jing and Huang, Ying and Ling, Li and Huang, Zhenjun and Zhu, Xianhua},
  title = {Exploring the impact of N4-acetylcytidine modification in RNA on non-neoplastic disease: unveiling its role in pathogenesis and therapeutic opportunities},
  journal = {Briefings in Functional Genomics},
  year = {2025},
  doi = {10.1093/bfgp/elae020}
}
Kostenlos starten →